Evidence map›Paper›PMID 34343012›Full record

ReviewJCO global oncology2021

Management Approach to Acute Myeloid Leukemia Leveraging the Available Resources in View of the Latest Evidence: Consensus of the Saudi Society of Blood and Marrow Transplantation.

Bader Alahmari, Mohsen Alzahrani, Nawal Al Shehry, Osamah Tawfiq, Turki Alwasaidi, Ayman Alhejazi, Mohammed Bakkar, Amal Al Behainy, Mansour Radwi, Ahmed Alaskar

Abstract readReviewConsensus Statement
In one paragraph

Review in JCO global oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Association of genetic predisposition studies inSaudi journal of biological sciences · 2024
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Bader AlahmariDepartment of Oncology, Ministry of the National Guard-Health Affairs, Riyadh, Saudi Arabia.ORCID 0000-0002-6026-1347
Mohsen AlzahraniDepartment of Oncology, Ministry of the National Guard-Health Affairs, Riyadh, Saudi Arabia.
Nawal Al ShehryKing Fahad Medical City, Riyadh, Saudi Arabia.
Osamah TawfiqKing Saud University Medical City, King Saud University, Riyadh, Saudi Arabia.
Turki AlwasaidiKing Abdullah International Medical Research Center, Riyadh, Saudi Arabia.ORCID 0000-0001-7813-260X
Ayman AlhejaziDepartment of Oncology, Ministry of the National Guard-Health Affairs, Riyadh, Saudi Arabia.
Mohammed BakkarPrince Mohammed Bin Nasser Hospital, Jizan, Saudi Arabia.
Amal Al BehainyKing Fahad Hospital, Madinah, Al Madinah Al Munawarrah, Saudi Arabia.
Mansour RadwiFaculty of Medicine, University of Jeddah, Jeddah, Saudi Arabia.
Ahmed AlaskarDepartment of Oncology, Ministry of the National Guard-Health Affairs, Riyadh, Saudi Arabia.ORCID 0000-0002-0648-3256

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeAcute myeloid leukemia (AML) is the most prevalent acute leukemia in adults and is responsible for the majority of cancer-related mortality. In Saudi Arabia, leukemia is ranked the fifth most prevalent type of malignancy in adults. Our aim is to review existing epidemiologic data in Saudi Arabia and develop consensus guidelines for management of AML.

methodsWe review literature related to AML epidemiology, treatment patterns, and outcomes in Saudi Arabia, as well as literature related to the current advances in AML treatment. A panel of 10 experts from eight institutions in Saudi Arabia reviewed the literature and developed a consensus statement.

resultWe provide an update of the available AML epidemiologic data in Saudi Arabia and describe recent developments in the diagnostic workup, risk stratification, and treatment algorithm. The consensus recommendations for the management of AML in Saudi Arabia were developed.

conclusionThe recommendations are in parallel with the recent international guidelines for the diagnosis and management of AML.

Indexed as

Leukemia, Myeloid, AcuteMedicineBone MarrowHumansSaudi Arabia

Identifiers

PMID34343012
PMCPMC8457782

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.